Author

Lingjun Duan

OpenAlex ID: A5058189103

Discovery of SPH5030, a Selective, Potent, and Irreversible Tyrosine Kinase Inhibitor for HER2-Amplified and HER2-Mutant Cancer Treatment

2022 · Di Li, Yuanxiang Tu, et al. · Journal of Medicinal Chemistry · 12

Discovery of N-(6-Acetylpyridin-3-yl)-2-(4-(ethylsulfonyl)phenyl)acetamide derivatives as a novel series of selective RORγt antagonists

2026 · Bingbin Zhang, Zhuo Li, et al. · European Journal of Medicinal Chemistry

Works count: 2

Citation count: 12

H-index: 1

I10-index: 1